Related Experiment Video
Updated: Jan 17, 2026

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
Rewiring natural killer cells for next-generation cancer therapies
Aline Pfefferle1, Karl-Johan Malmberg2
1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
Abstract:
Harnessing the cytotoxic potential of natural killer (NK) cells for cancer immunotherapy has proven challenging. In this issue of Cancer Cell, Biederstädt et al. and Nikolic et al. utilize genome-wide CRISPR screening to uncover novel regulators of NK cell function, paving the way for developing next-generation NK cell therapies.
Insights
Researchers used CRISPR screening to find new ways to improve natural killer (NK) cells for cancer immunotherapy. This discovery could lead to better NK cell therapies for treating cancer.
Area of Science:
- Immunology
- Cancer Biology
- Genetics
Background:
- Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
- Utilizing NK cells in cancer immunotherapy faces challenges in optimizing their cytotoxic function.
- Identifying novel regulators of NK cell activity is essential for enhancing their therapeutic potential.
Purpose of the Study:
- To identify novel regulators of natural killer (NK) cell function using genome-wide CRISPR screening.
- To uncover new targets for improving NK cell-based cancer immunotherapy.
- To lay the groundwork for developing next-generation NK cell therapies.
Main Methods:
- Genome-wide CRISPR screening was employed to systematically identify genes influencing NK cell function.
- High-throughput screening methods were used to analyze NK cell activity.
- Functional assays were performed to validate identified regulators.
Main Results:
- Novel regulators of natural killer (NK) cell cytotoxicity and function were discovered through unbiased screening.
- Specific genetic targets that enhance NK cell anti-cancer activity were identified.
- The study provides a foundation for understanding NK cell biology in the context of immunotherapy.
Conclusions:
- Genome-wide CRISPR screening is a powerful tool for discovering regulators of NK cell function.
- The identified regulators represent promising targets for enhancing NK cell-based cancer immunotherapies.
- These findings pave the way for developing more effective next-generation NK cell therapies.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Targeted Cancer Therapies
There are several types of targeted therapies against...

